Literature DB >> 24127231

Rapid determination of quetiapine in blood by gas chromatography-mass spectrometry. Application to post-mortem cases.

Olga López-Guarnido1, María Jesús Tabernero, Antonio F Hernández, Lourdes Rodrigo, Ana M Bermejo.   

Abstract

A simple, fast and sensitive method for the determination of quetiapine in human blood has been developed and validated. The method involved a basic liquid-liquid extraction procedure and subsequent analysis by gas chromatography-mass spectrometry, previous derivatization with bis(trimethylsilyl)-trifluoro-acetamide and chorotrimethylsilane (99 : 1). The methods of validation included linearity with a correlation coefficient > 0.99 over the range 0.02-1 µg ml(-1), intra- and interday precision (always < 12%) and accuracy (mean relative error always < 12%) to meet the bioanalytical acceptance criteria. The limit of detection was 0.005 µg ml(-1). The procedure was further applied to post mortems from the Institute of Legal Medicine, University of Santiago de Compostela.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  GC/MS; blood analysis; forensic toxicology; liquid-liquid extraction; quetiapine

Mesh:

Substances:

Year:  2013        PMID: 24127231     DOI: 10.1002/jat.2944

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  2 in total

1.  Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS).

Authors:  Zhuodu Wei; Hyeon-Cheol Jeong; Ye-Ji Kang; Jaesang Jang; Myoung-Hwan Kim; Kwang-Hee Shin
Journal:  Transl Clin Pharmacol       Date:  2022-06-15

2.  A rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study.

Authors:  Xiujuan Chen; Chen Liang; Lijun Cui; Jian Le; Zheyuan Qian; Runsheng Zhang; Zhanying Hong; Yifeng Chai
Journal:  J Food Drug Anal       Date:  2018-08-14       Impact factor: 6.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.